On May 25, 2023, Salarius Pharmaceuticals, Inc. closed the transaction. The transaction included participation from a single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5074 USD | +4.15% | -3.83% | -21.94% |
03-25 | Wall Street Set to Open Modestly Lower Monday Ahead of Housing, Inflation Data | MT |
03-25 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.94% | 2.1M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- SLRX Stock
- News Salarius Pharmaceuticals, Inc.
- Salarius Pharmaceuticals, Inc. announced that it has received $6.000001 million in funding